Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients

Seminars in Arthritis and Rheumatism
José A Gómez-PuertaJosep Font

Abstract

To describe the different types of malignancies associated with antiphospholipid antibodies (aPL). We performed a computer-assisted (MEDLINE, National Library of Medicine, Bethesda, MD) search of the literature from 1966 to 2003 to identify all cases of malignancies having aPL. One hundred twenty patients were found. The mean age was 56+/-17 years (range 5 to 88). Sixty-two (52%) patients were men and 58 (48%) were women. A heterogeneous group of malignancies were found. Regarding hematological malignancies, 10 (8%) patients suffered from B-cell lymphoma, 8 (7%) from spleen lymphoma, 7 (6%) from chronic myeloid leukemia, and 6 (5%) from non-Hodgkin's lymphoma (NHL). Regarding solid tumors, renal cell carcinoma was diagnosed in 7 (6%) patients, primary tumor with unknown origin in 7 (6%), lung adenocarcinoma in 6 (5%), breast carcinoma in 6 (5%), and melanoma in 6 (5%). The main aPL-related manifestations were thrombocytopenia (25%), cerebrovascular accidents (24%), deep vein thrombosis (19%), pulmonary embolism (15%), and heart valve lesions (9%). In 17 cases, catastrophic antiphospholipid syndrome was considered to be triggered by the malignancy. Seventy-one (63%) of 113 patients recovered or are still alive after cancer treat...Continue Reading

References

Dec 1, 1979·Arthritis and Rheumatism·R M Marcus, A I Grayzel
Oct 15, 1992·The New England Journal of Medicine·P PrandoniJ W ten Cate
Oct 1, 1989·British Journal of Haematology·V BellottiE Ascari
Sep 1, 1987·Postgraduate Medical Journal·C L KozlowskiR F Willey
Jun 1, 1987·Archives of Neurology·S R LevineK M Welch
May 1, 1994·Annals of Hematology·M SawamuraJ Tsuchiya
Jan 1, 1994·The British Journal of Dermatology·V A HillN P Smith
Nov 26, 1997·American Journal of Hematology·H MurakamiM Kojima
Feb 14, 1998·American Journal of Hematology·I S LossosY Matzner
Aug 26, 1998·Journal of Clinical Pathology·P T MurphyJ K Wood
Feb 26, 1999·Bone Marrow Transplantation·J I OlallaA Zubizarreta
May 18, 1999·Pediatric Neurology·E LiuS L Pomeroy
Sep 10, 1999·La Revue de médecine interne·V JullienP Dujardin
Nov 30, 1999·Annals of Internal Medicine·J C PietteA Foucher-Lavergne
Dec 22, 1999·American Journal of Hematology·J F ViallardM Parrens
Aug 12, 2000·Japanese Journal of Clinical Oncology·M H YangC C Yen
Jul 31, 2001·American Journal of Ophthalmology·N A Al-AbdullaS E LaBorwit
Mar 12, 2002·British Journal of Haematology·Teresa GallartJordi Vives
Mar 23, 2002·The Lancet Oncology·Gregory Y H LipAndrew D Blann
Oct 31, 2002·Cerebrovascular Diseases·Jong S Kim, Eun J Choi
Mar 8, 2003·International Journal of Cardiovascular Interventions·D F MuirN Curzen
Apr 1, 2003·American Journal of Hematology·Stephan MollDavid B Thomas
Jun 20, 2003·Circulation·Agnes Y Y Lee, Mark N Levine
Jul 23, 2003·Lupus·M GattornoA Martini
Sep 13, 2003·Chest·Frederick R RicklesPatricia M Fernandez

❮ Previous
Next ❯

Citations

Jun 21, 2011·Autoimmune Diseases·E KoumatiK Zachou
Jul 20, 2011·Leukemia & Lymphoma·Klaus LechnerIngrid Pabinger
May 1, 2007·Expert Review of Clinical Immunology·Ricard Cervera, Ronald A Asherson
Oct 20, 2015·Forensic Science, Medicine, and Pathology·John D Gilbert, Roger W Byard
Dec 24, 2013·Advances in Chronic Kidney Disease·Randy L Luciano, Ursula C Brewster
Nov 15, 2011·Rheumatic Diseases Clinics of North America·Félix Fernández Madrid, Marie-Claire Maroun
Apr 26, 2011·Critical Reviews in Oncology/hematology·Maria-Theresa KrauthKlaus Lechner
Apr 24, 2009·Autoimmunity Reviews·A TincaniR Cattaneo
Feb 3, 2009·Autoimmunity Reviews·Ernesto de MeisRoger A Levy
May 6, 2008·Pathologie-biologie·M-L Scrobohaci
Jan 22, 2008·Hematology/oncology Clinics of North America·Chi Pham, Yu-Min Shen
Nov 21, 2007·Thrombosis Research·Hervé DecoususPatrick Mismetti
Aug 2, 2006·Rheumatic Diseases Clinics of North America·Ricard CerveraJosep Font
Sep 26, 2007·Annals of the New York Academy of Sciences·Ronald A AshersonYehuda Shoenfeld
Sep 7, 2007·Annals of the New York Academy of Sciences·Ernesto De MeisRoger A Levy
Nov 19, 2011·Journal of Veterinary Internal Medicine·L N NielsenA T Kristensen
Dec 2, 2006·Autoimmunity Reviews·Ronald A Asherson
Dec 23, 2014·International Journal of Rheumatic Diseases·Yosra CherifZouhir Bahloul
Jan 24, 2007·American Journal of Obstetrics and Gynecology·Norbert Gleicher
Apr 10, 2015·Current Rheumatology Reports·Cassyanne L AguiarBarry L Myones
Jun 24, 2016·Clinical and Experimental Medicine·Simone NegriniFrancesco Puppo
Jul 7, 2016·American Journal of Hematology·Darko AnticBiljana Mihaljevic
Oct 20, 2010·Autoimmunity Reviews·Carme FontJoan C Reverter
Dec 20, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Schuharazad AbroMarcus Quek
Dec 3, 2008·Clinical Reviews in Allergy & Immunology·Wolfgang Miesbach
Mar 1, 2014·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A A SolimanG-F von Tempelhoff
Jun 29, 2017·Gynecologic Oncology·Mathieu ViauMarie Plante
Dec 22, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Jee-Soo LeeHyun Kyung Kim
Sep 9, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Daniel Navarro-CarpentieriAbraham Majluf-Cruz
Oct 6, 2007·Clinical Reviews in Allergy & Immunology·Eyal Reinstein, Yehuda Shoenfeld
Dec 27, 2007·Yonsei Medical Journal·Penka A Atanassova
Sep 29, 2009·Internal and Emergency Medicine·Mario BazzanPaolo Prandoni
Jun 21, 2019·Journal of Oral Science·Kohei OkuyamaMasahiro Umeda
Jan 21, 2020·Journal of Internal Medicine·E Svenungsson, A Antovic
Nov 26, 2010·Expert Review of Hematology·Hau C Kwaan, Timothy Huyck
May 11, 2011·Pathophysiology of Haemostasis and Thrombosis·Mehmet Ali CikrikciogluTufan Tukek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.